Stock listing

In8bio, Inc.

Selected listing: A4197Y · LSX · EUR · DE

In8bio, Inc. (LS Exchange: A4197Y), Health Technology. Latest release Oct 6, 2026: IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).

A4197Y:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A4197Y
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LS Exchange
Currency: EUR

Latest news from In8bio, Inc.

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

October 6, 2026

IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference

September 10, 2026

IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development

September 9, 2026

IN8bio Reports Inducement Grant under Nasdaq Listing Rule 5635(4)

August 11, 2026

IN8bio Reports Second Quarter 2026 Financial Results and Recent Business Highlights

August 6, 2026

All In8bio, Inc. news →

Events

Replays

IN8bio, Inc. (INAB) Q1 2022 Earnings Call
Tue, May 17, 2022 · 06:00 PM ET
Watch

Research In8bio, Inc.

In8bio, Inc. company profile

View the public company page for In8bio, Inc. on 6ix.

In8bio, Inc. news

Read company news and market updates connected to In8bio, Inc..

In8bio, Inc. investor events

Find investor webinars, events, and replay context for In8bio, Inc..